Prospective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages

Thrombosis and Haemostasis

Volumn 77, Issue 6, 1997, Pages 1096-1103

  Gris, Jean Christophe ^a,b   Ripart Neveu, Sylvie ^a   Maugard, Claude ^a   Tailland, Marie Laure ^a   Brun, Sophie ^a   Courtieu, Christophe ^a   Biron, Christine ^c   Hoffet, Méderic ^a   Hédon, Bernard ^c   Marès, Pierre ^b  

^a NÎMES UNIVERSITY HOSPITAL   (France)

^b UNIV MONTPELLIER   (France)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN; BLOOD CLOTTING FACTOR 12; C REACTIVE PROTEIN; PHOSPHOLIPID ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEIN C; PROTEIN S; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR; ANTIGEN; VON WILLEBRAND ANTIGEN;

ADULT; ARTICLE; BLOOD CLOTTING FACTOR 12 DEFICIENCY; CONTROLLED STUDY; FEMALE; FIBRINOGEN DEFECT; FIBRINOLYSIS; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; SPONTANEOUS ABORTION; VEIN OCCLUSION; VON WILLEBRAND DISEASE; BLOOD; COMPARATIVE STUDY; PATHOPHYSIOLOGY; PREGNANCY; PROSPECTIVE STUDY; RECURRENT ABORTION;

ABORTION, HABITUAL; ADULT; ANTIGENS; FACTOR XII DEFICIENCY; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMANS; PREGNANCY; PROSPECTIVE STUDIES;

EID: 0031155778     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1656119     Document Type: Article

References (51)

1. Poland BJ, Miller JR, Jones DC, Trimble BK. Reproductive counselling in patients who have had a spontaneous abortion. Am J Obstet Gynecol 1977; 127: 685-91.
2. Stray-Pederson B, Stray-Pederson S. Etiologic factors and subsequent reproductive performances in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 1984; 148: 142-6.
3. Berry CW, Brambati B, Eskes TKAB, Exalto N, Fox H, Geraedts JPM, Gerhard I, Gonzales-Gomes F, Grudzinskas JG, Hustin J, Jouppila P, Lindblom BKA, Mantoni M, Montenegro N, Nogales-Fernandes F, O'Rahilly R, Pederson JF, Peters PWJ, Regan L, Rushton DI, van Straaten HWM, Tarlatzis BC, Wells M. The Euro-team early pregnancy (ETAP) protocol for recurrent miscarriage. Hum Reprod 1995; 10: 1516-20.
4. Haan L, Lundberg PA. Congenital hypofibrinogenemia and recurrent abortion. Br J Obstet Gynaecol 1978; 85: 790-3.
5. Duckert F. The fibrin stabilizing factor, factor XIII. Blut 1973; 26: 177-9.
6. Triplett DA, Exner EN. Antiphospholipid antibodies and reproduction. Am J Reprod Immunol 1989; 21: 123-31.
7. Schved JF, Gris JC, Neveu S, Dupaigne D, Marès P. Factor XII congenital deficiency and early spontaneous abortion. Fertil Steril 1989; 52: 335-6.
8. Gris JC, Neveu S, Marès P, Biron C, Hedon B, Schved JF. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology. J Lab Clin Med 1993; 122: 606-15.
9. Constant G, Gouault-Heilmann M, Martinolli JL. Heparin inactivation during blood storage. Its prevention by blood collection in citric acid, theophylline, adenosine, dipyridamol - CTAD mixture. Thromb Res 1983; 31: 365-74.
10. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung der Fibrinogene. Acta Hematol (Basel) 1957; 17: 237-46.
11. Halbmayer WM, Haushofer A, Angerer V, Fischer M. The discrimination of factor XII deficiency and lupus anticoagulant. Thromb Haemost 1996; 75: 698-9.
12. Odegard OR, Lie M, Abildgaard U. Heparin cofactors activity measured by an amidolytic method. Thromb Res 1975; 6: 287-294.
13. Martinolli JL, Stocker K. Fast functional protein C assay using protac, a novel protein C activator. Thromb Res 1986; 43: 253-4.
14. Wolf M, Boyer-Neumann C, Martinolli JL. A new functional assay for human protein S activity using activated factor V as substrate. Thromb Haemost 1989; 4: 1144-5.
15. Cejka J. Performance characteristics of a commercial kit for assay of factor VIII-related antigen. Clin Chem 1984; 30: 1512-6.
16. Caen J, Larrieu MJ, Samama eds. L'hémostase. Méthodes d'exploration et diagnostic pratique. Paris: Expansion Scientifique Française, 1975: 256.
17. Holvoet P, Cleemput H, Collen D. Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three monoclonal antibodies. Thromb Haemost 1985; 54: 684-7.
18. Eriksson E, Ranby M, Gysander E, Risberg B. Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay. Thromb Res 1988; 50: 91-101.
19. Exner T, Rickard KA, Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haematol 1978; 40: 143-51.
20. Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood 1986; 68: 869-74.
21. Schleider NA, Nachman RL, Jaffe EA, Coleman N. A clinical study of the lupus anticoagulant. Blood 1976; 48: 499-509.
22. Triplett DA, Brandt JT, Kaczar D, Schaeffer J. Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. Am J Clin Pathol 1983; 79: 678-82.
23. Rauch J, Tannenbaum M, Janoff AS. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids. Thromb Haemost 1989; 62: 892-6.
24. Rosove MH, Ismail M, Koziol BJ, Runge A, Kasper CK. Lupus anticoagulants: improved diagnosis with a kaolin clotting time using rabbit brain phospholipid in standard and high concentrations. Blood 1986; 68: 472-8.
25. Reber G, Arvieux J, Comby E, Degenne D, de Moerloose P, Sanmarco M, Potron G. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. Thromb Haemost 1995; 73: 444-52.
26. Rosén S, Johansson K, Lindberg K, Dahlbäck B. Multicenter evaluation of a kit for activated protein C resistance on various coagulation instruments using plasmas from healthy individuals. Thromb Haemost 1994; 72: 255-60.
27. Boneu B, Bes G, Pelze H, Sie P, Bocalon H. D-dimer, thrombin-antithrombin III complexes and prothrombin fragments 1+2: diagnostic value in clinically suspected deep vein thrombosis. Thromb Haemost 1991; 65: 28-32.
28. Braulke I, Pruggmayer M, Melloh P. Factor XII (Hageman) deficiency in women with habitual abortion: new subpopulation of recurrent aborters? Fertil Steril 1993; 59: 98-101.
29. Mannhalter C, Fisher M, Hopmeier P, Deutsch E. factor XII activity and antigen concentrations in patients suffering from recurrent thrombosis. Fibrinolysis 1987; 1: 259-63.
30. Healy AM, Rayburn HB, Rosenberg RD, Weiler H. Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc Natl Acad Sci USA 1995; 92: 850-4.
31. Sanson BJ, Friederich PW, Simioni P, Zanardi S, Huisman MV, Girolami A, ten Cate JW, Prins MH. The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thromb Haemost 1996; 75: 387-8.
32. Preston FE, Rosendaal FR, Walker ID, Briët E, Berntorp E, Conard J, Fontcuberta J, Makris M, Mariani G, Noteboom W, Pabinger I, Legnani C, Scharrer I, Schulman S, van der Meer FJM. Increased foetal loss in women with heritable thrombophilia. Lancet 1996; 348: 313-6.
33. MacLean MA, Cumming GP, McCall F, Walker ID, Walker JJ. The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages. Br J Obstet Gynaecol 1994; 101: 103-6.
34. Goldberg SN, Conti-Kelly AM, Greco TP. A family study of anticardiolipin antibodies and associated clinical conditions. Am J Med 1995; 98: 473-9.
35. Parazzini F, Acaia B, Faden D, Lovotti M, Marelli G, Cortelazzo S. Antiphospholipid antibodies and recurrent abortion. Obstet Gynecol 1991; 77: 854-8.
36. Hunt JE, McNeil HP, Morgan GJ, Crameri RM, Krilis SA. A phospholipid-beta2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1992; 1: 75-81.
37. Aoki KA, Dubkiewicz AB, Matsuura E, Novotny M, Kaberlein G, Gleicher N. Clinical significance of beta2-glycoprotein I-dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: correlation with conventional antiphospholipid antibody detection system. J Obstet Gynecol 1995; 172: 926-31.
38. Shelton AJ, Harger JH, Dorman JS, Kuller LH, LaPorte RE, Gill III TJ. Association between familial autoimmune diseases and recurrent spontaneous abortions. Am J Reprod Immunol 1994; 32: 82-7.
39. Gris JC, Schved JF, Neveu S, Aguilar-Martinez P, Dupaigne D, Marès P. Impaired fibrinolytic capacity and early recurrent abortion of unknown etiology. Br Med J 1990; 300: 1500.
40. Patrassi GM, Sartori MT, Ruffatti A, Viero M, Di Lenardo L, Cazzanello D, Ghirardello A, Boeri G, Saggiorato G, Girolami A. Fibrinolytic pattern in recurrent spontaneous abortions: no relationship between hypofibrinolysis and anti-phospholipid antibodies. Am J Hematol 1994; 47: 266-72.
41. Petaja J, Rasi V, Vahtera E, Myllyla G. Familial clustering of defective release of t-PA. Br J Haematol 1991; 79: 291-5.
42. Jorgensen M, Bonnevie-Nielsen V. Increased concentrations of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis. Br J Haematol 1987; 65: 175-80.
43. Juhan-Vague I, Vague P, Alessi MC. Relationship between plasma insulin, triglyceride, body mass index, and plasminogen activator inhibitor 1. Diabete Metab 1987; 13: 331-6.
44. Juhan-Vague I, Roui C, Alessi MC, Ardissone JP, Heim M, Vague P. Increased plasminogen activator inhibitor activity in non-insulin dependent diabetic patients - Relationship with plasma insulin. Thromb Haemost 1989; 61: 370-3.
45. Juhan-Vague I, Aillaud MF, De Cock F. The fast-acting inhibitor of tissue-type plasminogen activator is an acute phase reactant protein. In: Davidson JF, Donati MB, Coccheri S, eds. Progress in fibrinolysis (vol. VII). Edinburgh: Churchill Livingstone, 1985: 146-9.
46. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW, for the E.C.A.T. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635-41.
47. Winkelstein W Jr, Stenchever MA, Lilienfeld AM. Occurrence of pregnancy, abortion and artificial menopause among women with coronary heart disease. J Chron Dis 1958; 7: 273-86.
48. Rushton DI. Placental pathology in spontaneous miscarriage. In: Early pregnancy loss. Beard RW, Sharp F (eds). London: Springer 1988; pp 149-56.
49. Archipoff G, Beretz A, Freyssinet JM, Klein-Soyer C, Brisson C, Cazanave JP. Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumor necrosis factor, thrombin or phorbol ester. Biochem J 1991; 273: 679-84.
50. Mallmann P, Werner A, Krebs D. Serum levels of interleukin-2 and tumor necrosis factor alpha in women with recurrent abortion. Lancet 1994; 163: 1367.
51. Ferari DA, Gilles PA, Klein NW, Nadler D, Weeks BS, Lammi-Keefe CJ. Rat embryo development on human sera is related to numbers of previous spontaneous abortions and nutritional factors. Am J Obstet Gynecol 1994; 170: 228-36.